Bionova Pharmaceuticals
AcquiredBionova Pharmaceuticals is an oncology company in Shanghai, China, founded in 2018.
- Headquarters
- Shanghai
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- bionovapharma.com
- Acquisition Date
- May 2025
Indexed holds 1 investor for this company. The full record is or through the API.
About
BioNova Pharmaceuticals (Shanghai) Limited is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of innovative medicines for cancer and other life-threatening diseases with high unmet medical needs. The company builds its pipeline through internal R&D programs as well as collaborations with and acquisitions from partners with cutting-edge technology, including small molecule inhibitors and targeted therapeutics such as BN101 (graft-versus-host disease), BN102 (BTK inhibitor), and BN103/BN104 targeting hematologic malignancies. Founded in 2018 and headquartered in Shanghai, BioNova operates as a fast-growing organization backed by investors including Mitsui & Co. Global Investment.
Summary
It lists 1–10 employees. Investors include Servier Ventures.
Exit History
May 2025
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Novel bicyclic peptides and drug conjugates for cancer
Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/bionova-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/bionova-pharmaceuticals" alt="Bionova Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>